Plain-English translation of NCT03858777 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Sarcoidosis is an immune disease that can affect the heart in ways that are hard to detect with current tests. This study is investigating whether a special blood test—looking for cell-free DNA from heart cells—can identify when the heart is being damaged by sarcoidosis inflammation. The goal is to create a simple, reliable way to catch heart involvement early before it causes serious problems.
Heart involvement from sarcoidosis is dangerous and often goes undiagnosed because current imaging tests like MRI and PET scans have limitations and aren't always available. A simple blood test could help doctors identify patients with active heart inflammation who need urgent treatment, and potentially prevent life-threatening complications like heart failure or dangerous heart rhythms.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have one or two simple blood draws depending on your group—people without active heart inflammation will have one draw, while those with active inflammation will have two draws two months apart. The study also includes people who have had a heart attack and healthy volunteers for comparison. The entire process is straightforward: a nurse will take a blood sample, and researchers will analyze it to see if the blood test can reliably detect heart inflammation from sarcoidosis.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States